ATE29890T1 - Retroinversoanalog des (5-14)-decapeptids von equin angiotensinogen als spezifischer renininhibitor mit hoher bestaendigkeit gegenueber enzymatischer hydrolyse. - Google Patents

Retroinversoanalog des (5-14)-decapeptids von equin angiotensinogen als spezifischer renininhibitor mit hoher bestaendigkeit gegenueber enzymatischer hydrolyse.

Info

Publication number
ATE29890T1
ATE29890T1 AT84200710T AT84200710T ATE29890T1 AT E29890 T1 ATE29890 T1 AT E29890T1 AT 84200710 T AT84200710 T AT 84200710T AT 84200710 T AT84200710 T AT 84200710T AT E29890 T1 ATE29890 T1 AT E29890T1
Authority
AT
Austria
Prior art keywords
angiotensinogen
decapeptide
high resistance
equin
enzymatic hydrolysis
Prior art date
Application number
AT84200710T
Other languages
English (en)
Inventor
Massimo Pinori
Antonio Silvio Verdini
Original Assignee
Eni Ente Naz Idrocarb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eni Ente Naz Idrocarb filed Critical Eni Ente Naz Idrocarb
Application granted granted Critical
Publication of ATE29890T1 publication Critical patent/ATE29890T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02Linear peptides containing at least one abnormal peptide link
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0212Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -N-C-N-C(=0)-, e.g. retro-inverso peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/86Renin inhibitors
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/32Modification to prevent enzymatic degradation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
AT84200710T 1983-05-25 1984-05-17 Retroinversoanalog des (5-14)-decapeptids von equin angiotensinogen als spezifischer renininhibitor mit hoher bestaendigkeit gegenueber enzymatischer hydrolyse. ATE29890T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT21281/83A IT1164239B (it) 1983-05-25 1983-05-25 Un retro-inverso analogo del decapeptide (5-14)dell'angiotensinogeno equino inibitore specifico della renina con elevata resistenza all'idrolisi enzimatica
EP84200710A EP0127234B1 (de) 1983-05-25 1984-05-17 Retroinversoanalog des (5-14)-Decapeptids von Equin Angiotensinogen als spezifischer Renininhibitor mit hoher Beständigkeit gegenüber enzymatischer Hydrolyse

Publications (1)

Publication Number Publication Date
ATE29890T1 true ATE29890T1 (de) 1987-10-15

Family

ID=11179480

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84200710T ATE29890T1 (de) 1983-05-25 1984-05-17 Retroinversoanalog des (5-14)-decapeptids von equin angiotensinogen als spezifischer renininhibitor mit hoher bestaendigkeit gegenueber enzymatischer hydrolyse.

Country Status (8)

Country Link
US (1) US4560505A (de)
EP (1) EP0127234B1 (de)
JP (1) JPH0672153B2 (de)
AT (1) ATE29890T1 (de)
AU (1) AU558572B2 (de)
CA (1) CA1249699A (de)
DE (1) DE3466396D1 (de)
IT (1) IT1164239B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1190389B (it) * 1985-09-19 1988-02-16 Eniricerche Spa Esapeptidi ad attivita' ipotensiva
ES2052517T3 (es) * 1986-07-16 1994-07-16 Eniricerche Spa Analogos de tuftsina parcialmente retroinversos, metodo de preparacion de los mismos y composiciones farmaceuticas que los contienen.
ATE107658T1 (de) * 1988-01-26 1994-07-15 Sankyo Co Renin inhibierende polypeptide, ihre herstellung und anwendung.
US5807979A (en) * 1988-04-08 1998-09-15 The Scripps Research Institute Synthetic, three-dimensionally stabilized polypeptide mimics of HIV
AU3534989A (en) * 1988-04-08 1989-11-03 Scripps Clinic And Research Foundation Polypeptides stabilized by covalent hydrogen bond replacements
DE4004820A1 (de) * 1989-08-05 1991-04-25 Bayer Ag Renininhibitoren, verfahren zur herstellung und ihre verwendung in arzneimitteln
US5242903A (en) * 1989-08-05 1993-09-07 Bayer Aktiengesellschaft Renin inhibitors
US6458357B1 (en) 1997-09-09 2002-10-01 Myelos Corporation Retro-inverso neurotrophic and analgesic peptides
CA2520257A1 (en) * 2003-03-24 2004-10-07 Sequoia Pharmaceuticals, Inc. Long acting biologically active conjugates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4269827A (en) * 1980-06-23 1981-05-26 The Massachusetts General Hospital Process and composition for reducing blood pressure
NO812612L (no) * 1980-08-06 1982-02-08 Ferring Pharma Ltd Enzym-inhibitorer.
JPS5759846A (en) * 1980-08-06 1982-04-10 Ferring Pharma Ltd Polypeptide homologue and manufacture of hydroxy or keto homologue of dipeptide
IT1212508B (it) * 1981-12-22 1989-11-22 Anic Spa Analoghi retro - invertiti dei penta - ed esapeptidi c - terminali della sostanza p. utili come vasodilatatori
IT1190891B (it) * 1982-06-24 1988-02-24 Anic Spa Metodo per la sintesi in fase solida di polipeptidi retroinvertiti

Also Published As

Publication number Publication date
IT8321281A1 (it) 1984-11-25
US4560505A (en) 1985-12-24
AU558572B2 (en) 1987-02-05
EP0127234B1 (de) 1987-09-23
DE3466396D1 (en) 1987-10-29
JPS59231055A (ja) 1984-12-25
EP0127234A3 (en) 1985-09-04
IT1164239B (it) 1987-04-08
CA1249699A (en) 1989-01-31
JPH0672153B2 (ja) 1994-09-14
EP0127234A2 (de) 1984-12-05
AU2855384A (en) 1984-11-29
IT8321281A0 (it) 1983-05-25

Similar Documents

Publication Publication Date Title
ATE44533T1 (de) Hemmen von enzymen.
PT956282E (pt) Derivados de acido sulfinico e sua preparacao e utilizacao
ATE220317T1 (de) Verwendung von betainen als antitranspirantien
ATE250669T1 (de) Proteolytische enzyme und ihre verwendung in waschmitteln
DE69021530D1 (de) Neue Derivate von A-nor-3-Carboxysteroiden.
ATE29890T1 (de) Retroinversoanalog des (5-14)-decapeptids von equin angiotensinogen als spezifischer renininhibitor mit hoher bestaendigkeit gegenueber enzymatischer hydrolyse.
ATE24516T1 (de) Amino- und substituierte aminophosphinylalkanoyl- verbindungen.
TR199802079T2 (xx) D-Manitol ve haz�rlanmas�.
MX9305784A (es) N-(aceilaminometil) glutaril amino acidos.
DE69031271D1 (de) Varianten von pai-2
DE59304680D1 (de) Verfahren zur reinigung von perfluorkohlenstoffen
EA199800200A1 (ru) Ингибиторы пролилэндопептидазы
ATE38043T1 (de) Teilweise retro-invertiertes decapeptid als spezifischer renininhibitor mit hoher bestaendigkeit gegenueber enzymatischer hydrolyse.
SE9402027D0 (sv) Energy substrates
ES2037069T3 (es) Procedimiento de fabricacion de oxidos metalicos vitreos.
DE69734378D1 (de) An der Regenierung von Luciferin beteiligtes Enzym
DE69518246D1 (de) Aminosäuren konjugaten
ATE267209T1 (de) Reinigung von carboxaldehyd
DE69708143D1 (de) N-acetyl aminoethoxyvinylglycin (avg) und seine verwendung als ethylenbiossythese-inhibitor
ATE199547T1 (de) Arylalkoxyphenoxyimidazolinverbindungen
FR2426685A2 (fr) Derives d'acides thiazolidinecarboxyliques et d'acides apparentes, utiles comme agents anti-hypertension
ATE214923T1 (de) Verwendung von (r)-verapamil als medizin zur behandlung von angina
ATE125294T1 (de) Polypeptid-verbindungen.
ATE77952T1 (de) Verwendung von 1,4-dihydropyridinderivaten.
GR1001393B (el) Παράγωγα ιμιδαζο[2,1-Β] 3] βενζαζεπίνης, συν?έσεις και μέ?οδος χρήσεως.